Achieve Life Sciences earnings were -$46.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ACHV earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$12.8M, up 3.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ACHV reported annual earnings of -$39.8M, with 33.6% growth.
Achieve Life Sciences Earnings Reports & History FAQ
What were Achieve Life Sciences's earnings last quarter?
On ACHV's earnings call on Invalid Date, Achieve Life Sciences (NASDAQ: ACHV) reported Q1 2025 earnings per share (EPS) of -$0.37, up 42.31% year over year. Total ACHV earnings for the quarter were -$12.83 million. In the same quarter last year, Achieve Life Sciences's earnings per share (EPS) was -$0.26.
Is Achieve Life Sciences profitable or losing money?
As of the last Achieve Life Sciences earnings report, Achieve Life Sciences is currently losing money. Achieve Life Sciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$46.16 million, a 68.98% increase year over year.
What was ACHV's earnings growth in the past year?
As of Achieve Life Sciences's earnings date in Invalid Date, Achieve Life Sciences's earnings has grown year over year. ACHV earnings in the past year totalled -$46.16 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.